Oppenheimer Holdings Stock News

Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock analysts at Oppenheimer issued their Q2 2022 earnings per share (EPS) estimates for shares of Integral Ad Science in a report released on Thursday, November 11th. Oppenheimer analyst J. Helfstein anticipates that the company will post earnings of $0.01 per share for the quarter. Oppenheimer currently has []

WhiteHorse Finance, Inc. (NASDAQ:WHF) Stock analysts at Oppenheimer upped their Q4 2021 earnings estimates for shares of WhiteHorse Finance in a research report issued on Wednesday, November 10th. Oppenheimer analyst M. Penn now anticipates that the investment management company will earn $0.38 per share for the quarter, up from their previous forecast of $0.37. []

Aeva Technologies, Inc. (NYSE:AEVA) Oppenheimer decreased their FY2021 earnings per share estimates for Aeva Technologies in a report released on Thursday, November 11th. Oppenheimer analyst C. Rusch now forecasts that the company will post earnings per share of ($0.50) for the year, down from their previous estimate of ($0.42). Oppenheimer also issued estimates for []

Prometheus Biosciences (NASDAQ:RXDX) was downgraded by Oppenheimer from an outperform rating to a market perform rating in a research report issued to clients and investors on Monday, Price Targets.com reports. They currently have a $35.00 price objective on the biopharmaceutical companys stock. Oppenheimers price target points to a potential downside of 4.32% from the companys []

Gamida Cell (NASDAQ:GMDA) had its target price lowered by stock analysts at Oppenheimer from $17.00 to $15.00 in a report issued on Tuesday, The Fly reports. The firm currently has an outperform rating on the stock. Oppenheimers target price indicates a potential upside of 341.18% from the companys current price. A number of other equities []

Wells Fargo & Company assumed coverage on shares of Runway Growth Finance (NASDAQ:RWAY) in a report issued on Monday, PriceTargets.com reports. The firm issued an overweight rating and a $15.00 price target on the stock. A number of other research firms also recently commented on RWAY. Oppenheimer initiated coverage on Runway Growth Finance in a []

Gladstone Land Co. (NASDAQ:LAND) Research analysts at Oppenheimer reduced their Q4 2021 EPS estimates for Gladstone Land in a research note issued to investors on Thursday, November 11th. Oppenheimer analyst M. Penn now expects that the real estate investment trust will post earnings of $0.17 per share for the quarter, down from their prior []

Compass, Inc. (NYSE:COMP) Stock analysts at Oppenheimer raised their FY2021 earnings estimates for shares of Compass in a research report issued to clients and investors on Thursday, November 11th. Oppenheimer analyst J. Helfstein now forecasts that the company will post earnings of ($1.33) per share for the year, up from their prior estimate of []

ContextLogic Inc. (NASDAQ:WISH) Research analysts at Oppenheimer increased their FY2021 earnings per share (EPS) estimates for ContextLogic in a research report issued on Wednesday, November 10th. Oppenheimer analyst J. Helfstein now expects that the company will post earnings per share of ($0.57) for the year, up from their prior forecast of ($0.67). Oppenheimer has []

A price cut from an analyst had some traders hitting the sell button.

Wix.com (NASDAQ:WIX) had its target price cut by equities research analysts at Oppenheimer from $275.00 to $250.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an outperform rating on the information services providers stock. Oppenheimers price objective points to a potential upside of 25.04% from the []

Akamai Technologies (NASDAQ:AKAM) was downgraded by equities research analysts at Oppenheimer from an outperform rating to a market perform rating in a research note issued on Monday, The Fly reports. Several other analysts have also commented on AKAM. Royal Bank of Canada initiated coverage on shares of Akamai Technologies in a research report on Thursday, []

Workday (NASDAQ:WDAY)s stock had its outperform rating reaffirmed by research analysts at Oppenheimer in a research note issued to investors on Monday, The Fly reports. They currently have a $340.00 target price on the software makers stock, up from their prior target price of $285.00. Oppenheimers price target would indicate a potential upside of 14.69% []

NEW YORK, Nov. 15, 2021 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) today announced the launch of its new Global Fund Placement and Advisory Group ("FPA Group"). The FPA Group

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Equities researchers at Oppenheimer lifted their FY2021 earnings estimates for STRATA Skin Sciences in a research note issued to investors on Thursday, November 11th. Oppenheimer analyst S. Kalia now expects that the medical device company will post earnings of ($0.14) per share for the year, up from their prior []